These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2462945)

  • 1. The in vivo metabolism of recombinant human erythropoietin in the rat.
    Spivak JL; Hogans BB
    Blood; 1989 Jan; 73(1):90-9. PubMed ID: 2462945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of recombinant human erythropoietin in the rat.
    Spivak JL
    Adv Exp Med Biol; 1989; 271():29-38. PubMed ID: 2486287
    [No Abstract]   [Full Text] [Related]  

  • 3. Survival of recombinant erythropoietin in the circulation: the role of carbohydrates.
    Fukuda MN; Sasaki H; Lopez L; Fukuda M
    Blood; 1989 Jan; 73(1):84-9. PubMed ID: 2910371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of antennary structure of N-linked sugar chains in renal handling of recombinant human erythropoietin.
    Misaizu T; Matsuki S; Strickland TW; Takeuchi M; Kobata A; Takasaki S
    Blood; 1995 Dec; 86(11):4097-104. PubMed ID: 7492766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of recombinant human erythropoietin following multiple intravenous administration and effects of age on the distribution in rats.
    Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
    Arzneimittelforschung; 1992 Apr; 42(4):579-84. PubMed ID: 1642686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and distribution of recombinant erythropoietin in rats.
    Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
    Arzneimittelforschung; 1992 Feb; 42(2):174-8. PubMed ID: 1610430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of pure human erythropoietin in the rat.
    Emmanouel DS; Goldwasser E; Katz AI
    Am J Physiol; 1984 Jul; 247(1 Pt 2):F168-76. PubMed ID: 6742201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fate of recombinant human renin administered exogenously to anesthetized monkeys.
    Hiruma M; Kim S; Ikemoto F; Murakami K; Yamamoto K
    Hypertension; 1988 Sep; 12(3):317-23. PubMed ID: 3049339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo 125I-erythropoietin pharmacokinetics are unchanged after anesthesia, nephrectomy and hepatectomy in sheep.
    Widness JA; Veng-Pedersen P; Schmidt RL; Lowe LS; Kisthard JA; Peters C
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1205-10. PubMed ID: 8968342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics and distribution of human urinary erythropoietin and recombinant human erythropoietin in rats.
    Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
    Arzneimittelforschung; 1991 Sep; 41(9):1004-7. PubMed ID: 1796912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid clearance of human insulin-like growth factor binding protein-3 from the rat circulation and cellular localization in liver, kidney and stomach.
    Arany E; Zabel P; Hill DJ
    Growth Regul; 1996 Mar; 6(1):32-41. PubMed ID: 8717448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of erythropoietin in intact and anephric dogs.
    Fu JS; Lertora JJ; Brookins J; Rice JC; Fisher JW
    J Lab Clin Med; 1988 Jun; 111(6):669-76. PubMed ID: 3373111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical and biological characterization of asialoerythropoietin. Suppressive effects of sialic acid in the expression of biological activity of human erythropoietin in vitro.
    Imai N; Higuchi M; Kawamura A; Tomonoh K; Oh-Eda M; Fujiwara M; Shimonaka Y; Ochi N
    Eur J Biochem; 1990 Dec; 194(2):457-62. PubMed ID: 2269277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic clearance of rat plasma intestinal alkaline phosphatase.
    Young GP; Rose IS; Cropper S; Seetharam S; Alpers DH
    Am J Physiol; 1984 Oct; 247(4 Pt 1):G419-26. PubMed ID: 6496679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma disappearance and organ distribution of recombinant human tumor necrosis factor-alpha in rats.
    Pang XP; Hershman JM; Pekary AE
    Lymphokine Cytokine Res; 1991 Aug; 10(4):301-6. PubMed ID: 1932374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma clearance and tissue distribution of recombinant human platelet-derived growth factor (B-chain homodimer) in rats.
    Cohen AM; Soderberg C; Thomason A
    J Surg Res; 1990 Nov; 49(5):447-52. PubMed ID: 2246890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of iodine labeled recombinant human erythropoietin.
    Kinoshita H; Ohishi N; Okazaki A
    Arzneimittelforschung; 1991 May; 41(5):568-70. PubMed ID: 1898429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of radiolabelled recombinant human insulin-like growth factor binding protein-3 from the circulation, and its distribution amongst organs and tissues in adult male rats.
    Arany E; Zabel P; Freeman D; Hill DJ
    Regul Pept; 1993 Oct; 48(1-2):133-43. PubMed ID: 7505460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic clearance of intact and desialylated erythropoietin.
    Briggs DW; Fisher JW; George WJ
    Am J Physiol; 1974 Dec; 227(6):1385-8. PubMed ID: 4440781
    [No Abstract]   [Full Text] [Related]  

  • 20. A sensitive and specific erythropoietin immunoprecipitation assay: application to pharmacokinetic studies.
    Widness JA; Schmidt RL; Veng-Pedersen P; Modi NB; Sawyer ST
    J Lab Clin Med; 1992 Mar; 119(3):285-94. PubMed ID: 1311741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.